Option traders moderately bearish in Moderna (MRNA), with shares down 20c near $25.80. Options volume relatively light with 31k contracts traded and puts leading calls for a put/call ratio of 3.02, compared to a typical level near 0.54. Implied volatility (IV30) is higher by 2.2 points near 63.82,and below the 52wk median, suggesting an expected daily move of $1.04. Put-call skew steepened, indicating increased demand for downside protection.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNA:
- Moderna Faces Regulatory and Commercial Challenges Amidst Balance Sheet Vulnerabilities and Vaccine Setbacks
- VOO ETF News, 6/16/2025
- Moderna’s mRESVIA Vaccine Faces Market Challenges Despite FDA Approval
- Cautious Outlook on Moderna: Hold Rating Amid Regulatory Developments and Market Uncertainty
- Moderna receives FDA approval for RSV vaccine